Skip to search formSkip to main contentSkip to account menu

gemopatrilat

Known as: (6S)-Hexahydro-6-((alphaS)-alpha-mercaptohydrocinnamamido)-2,2-dimethyl-7-oxo-1H-azepine-1-acetic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
This study describes the pharmacokinetic parameters of gemopatrilat, a potent vasopeptidase inhibitor, in humans and the… 
2003
2003
BACKGROUND Control of blood pressure (BP) and optimal reduction of proteinuria (Uprot) are necessary for long-term renoprotection… 
Review
2002
Review
2002
  • G. Sagnella
  • Journal of the Renin-Angiotensin-Aldosterone…
  • 2002
  • Corpus ID: 24479593
Vasopeptidase inhibitors are a new class of drugs that have dual inhibitory effects on two key enzymes involved in the metabolism… 
Review
2002
Review
2002
Vasopeptidase inhibitors are a new class of drugs that have dual inhibitory effects on two key enzymes involved in the metabolism… 
2001
2001
Objectives Vasopeptidase inhibitors are single molecules that simultaneously inhibit neutral endopeptidase (NEP) and angiotensin…